US Patent 11505620 Methods of detecting plasma kallikrein
Patent 11505620 was granted and assigned to Takeda Pharmaceutical Company on November, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115056200
Date of Patent
November 22, 2022
0Patent Application Number
164112420
Date Filed
May 14, 2019
0Patent Citations
Patent Primary Examiner
Edits on 22 Apr, 2023
Golden AI
Infobox
Patent Citations
Golden AI
Infobox
Edits on 31 Mar, 2023
Golden AI
Infobox
Edits on 25 Nov, 2022
Golden AI
Edits made to:
Infobox (+19 properties)
Article (+84 characters)
US Patent 11505620 Methods of detecting plasma kallikrein
Article
Plasma kallikrein binding proteins and methods of using such proteins are described.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115056200
Date of Patent
November 22, 2022
0Patent Application Number
164112420
Date Filed
May 14, 2019
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11505620 Methods of detecting plasma kallikrein
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
